3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
3
Lymphoma
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Lymphoid
2
Burkitt Lymphoma
2
Shwachman-Diamond Syndrome
1
Preleukemia
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoproliferative Disorders
1
Lymphoma, Primary Effusion
1
Lymphatic Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Mast-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Leukemia
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hemoglobinuria, Paroxysmal
1
Hematologic Neoplasms
1
Hematologic Diseases
1
GATA2 Deficiency
1
Interventions
durvalumab
9
Bevacizumab
8
tremelimumab
4
lenvatinib
3
atezolizumab
3
Nivolumab
3
Ipilimumab
3
fludarabine
2
Magnetic Resonance Imaging
2
Hepatectomy
2
Gemcitabine
2
Cyclophosphamide
2
Cisplatin
2
trastuzumab deruxtecan
1
toripalimab
1
ropidoxuridine
1
poly ICLC
1
pembrolizumab
1
brodalumab
1
X-Rays
1
Whole Genome Sequencing
1
Technetium Tc 99m Aggregated Albumin
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiosurgery
1
Radionuclide Imaging
1
Pregabalin
1
Pluvicto
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Bone Marrow Transplantation
×
90 days
×
Clear all
No trials found.